Clinical Trials
7 trialsNCT05106023 2023-06-07
To Explore the Efficacy and Safety of SHR-1701 Combined With Temozolomide in the Treatment of Advanced Melanoma
Fudan University
Phase 2 Unknown
NCT04580498 2023-05-19
A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT04355858 2022-07-26
MULAN
Fudan University
Phase 2 Unknown
NCT05177497 2022-01-04
SHR-1701 for Consolidation Therapy After Concurrent Chemoradiotherapy in Inoperable Stage III NSCLC
Shanghai Chest Hospital
Phase 2 Unknown
NCT04650633 2021-10-29
SHR-1701 in Patients With Recurrent/Metastatic Scchn
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT04884009 2021-05-12
A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown
NCT04560244 2020-09-23
A Trial of SHR1701 Combined With Radiotherapy for Metastatic Non-small Cell Lung Cancer Failure After First-line Treatment
Shandong Cancer Hospital and Institute
Phase 2 Unknown